Viewing Study NCT04764656


Ignite Creation Date: 2025-12-24 @ 11:15 PM
Ignite Modification Date: 2025-12-25 @ 8:52 PM
Study NCT ID: NCT04764656
Status: TERMINATED
Last Update Posted: 2025-03-25
First Post: 2021-02-19
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Observational Study to Evaluate Fluid Resolution and Effectiveness of Brolucizumab for nAMD in Portugal
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module